spironolactone on the heart

Discussion in 'Step I' started by Lany, May 28, 2008.

  1. Lany

    2+ Year Member

    Joined:
    May 24, 2008
    Messages:
    41
    Likes Received:
    1
    Status:
    Medical Student
    spironolactone dec. mortality in class III and IV CHF pxts.

    in uworld "spironolactone in HF patients are more than likely secondary to inhibition of the neurohormonal effects of aldosterone leading to decreased ventricular remodeling and cardiac fibrosis". Can anyone explain it beyond this? what neurohormonal effect? Is it because spironolactone inhibits aldosterone working on the heart compared to other diuretics which decreases aldosterone altogether?
     
  2. 45408

    45408 aw buddy
    7+ Year Member

    Joined:
    Jun 13, 2004
    Messages:
    16,976
    Likes Received:
    44
    Status:
    Resident [Any Field]
    Ha, I think I had this question today or yesterday. Other diuretics (ACE inhibitors) that decrease aldosterone can eventually be overridden, and aldosterone then continues to exert its effects. If you directly block its receptor (spironolactone, eplerenone) in addition to blocking the renin-ang-aldo system (an ACE-i), then you can further prolong longevity.
     
  3. osli

    osli Senior Member
    5+ Year Member

    Joined:
    Oct 13, 2005
    Messages:
    1,279
    Likes Received:
    6
    Status:
    Medical Student
    Yeah, I think that's often referred to as the "aldosterone escape" of ACEi's and ARB's. Spironolactone does not suffer from aldosterone escape for the reason TheProwler stated above.
     
    Stop hovering to collapse... Click to collapse... Hover to expand... Click to expand...

Share This Page